학술논문
New Immune Globulin Subcutaneous (Human), 10% (IGSC) Product is Well Tolerated in Subjects with Primary Immunodeficiency Diseases (PIDD)
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology 2011 127(2) Supplement:AB16-AB16
Subject
Language
ISSN
0091-6749